Growth Metrics

Omeros (OMER) Shareholder's Equity Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -46.63%
Dec 31, 2025 -50.59%
Sep 30, 2025 -68.22%
Jun 30, 2025 -91.23%
Mar 31, 2025 -251.32%
Dec 31, 2024 -113.11%
Sep 30, 2024 16.28%
Jun 30, 2024 20.32%
Mar 31, 2024 31.50%
Dec 31, 2023 40.86%
Sep 30, 2023 45.74%
Jun 30, 2023 28.61%
Mar 31, 2023 34.19%
Dec 31, 2022 40.71%
Sep 30, 2022 30.82%
Jun 30, 2022 36.92%
Mar 31, 2022 65.60%
Dec 31, 2021 30.79%
Sep 30, 2021 -43.45%
Jun 30, 2021 -63.55%
Mar 31, 2021 -96.59%
Dec 31, 2020 -250.10%
Sep 30, 2020 -125.59%
Jun 30, 2020 -43.26%
Mar 31, 2020 -39.94%
Dec 31, 2019 -42.79%
Sep 30, 2019 -83.16%
Jun 30, 2019 -38.54%
Mar 31, 2019 -43.75%
Dec 31, 2018 -56.29%
Sep 30, 2018 -114.61%
Jun 30, 2018 -108.76%
Mar 31, 2018 -49.44%
Dec 31, 2017 59.59%
Sep 30, 2017 32.88%
Jun 30, 2017 -72.90%
Mar 31, 2017 -123.95%
Dec 31, 2016 -26.76%
Sep 30, 2016 1.59%
Jun 30, 2016 -58.71%
Mar 31, 2016 -36.94%
Dec 31, 2015 -58.96%
Sep 30, 2015 -122.27%
Jun 30, 2015 33.63%
Mar 31, 2015 54.98%
Dec 31, 2014 -97.30%
Sep 30, 2014 -104.26%
Jun 30, 2014 -45.17%
Dec 31, 2013 -42.57%